HIV-1 drug resistance in primary infections in the UK.

HIV-1 drug resistance in primary infections in the UK.

Dades bibliogràfiques
Autors principals:	Fidler, S, Frater, J, Clarke, J, Weber, J
Format:	Journal article
Idioma:	English
Publicat:	2001

Ítems similars

HIV-1 Specific CD4 Responses in Primary HIV-1 Infection predict disease progression in the SPARTAC Trial
per: Frater, A, et al.
Publicat: (2013)

Simple detection of point mutations associated with HIV-1 drug resistance.
per: Frater, A, et al.
Publicat: (2001)

Soluble plasma programmed death 1 (PD-1) and Tim-3 in primary HIV infection
per: Frater, J, et al.
Publicat: (2019)

Duration of HIV-1 viral suppression on cessation of antiretroviral therapy in primary infection correlates with time on therapy
per: Stöhr, W, et al.
Publicat: (2013)

Performance of two commercially available sequence-based HIV-1 genotyping systems for the detection of drug resistance against HIV type 1 group M subtypes.
per: Beddows, S, et al.
Publicat: (2003)

Short-course antiretroviral therapy in primary HIV infection.
per: Fidler, S, et al.
Publicat: (2013)

Exhaustion of activated CD8 T cells predicts disease progression in primary HIV-1 infection
per: Hoffmann, M, et al.
Publicat: (2016)

Virological and immunological effects of short-course antiretroviral therapy in primary HIV infection.
per: Fidler, S, et al.
Publicat: (2002)

Virological and immunological effects of short-course antiretroviral therapy in primary HIV infection.
per: Fidler, S, et al.
Publicat: (2002)

Human immunodeficiency virus (HIV)-specific T helper responses fail to predict CD4+ T cell decline following short-course treatment at primary HIV-1 infection.
per: Fox, J, et al.
Publicat: (2008)

Variable fate of virus-specific CD4(+) T cells during primary HIV-1 infection.
per: Oxenius, A, et al.
Publicat: (2001)

Increased levels of CD4 T-cell activation in individuals with CXCR4 using viruses in primary HIV-1 infection.
per: Hamlyn, E, et al.
Publicat: (2012)

Protective HLA class I alleles are associated with reduced immune activation and fibrinolysis in individuals with primary HIV infection
per: Hamlyn, E, et al.
Publicat: (2010)

Longitudinal analysis of an HLA-B*51-restricted epitope in integrase reveals immune escape in early HIV-1 infection.
per: Yager, N, et al.
Publicat: (2013)

Vedolizumab use and the associations between α4β7 expression and HIV reservoir in the gut during treated primary HIV infection
per: Thornhill, JP, et al.
Publicat: (2019)

HIV-1 resistance genotyping by sequencing produces inconsistent results for mixed viral populations.
per: Frater, A, et al.
Publicat: (2000)

Comparative response of African HIV-1-infected individuals to highly active antiretroviral therapy.
per: Frater, A, et al.
Publicat: (2002)

Post-treatment control or treated controllers? Viral remission in treated and untreated primary HIV infection
per: Martin, G, et al.
Publicat: (2017)

Virological blips and predictors of post treatment viral control after stopping ART started in primary HIV infection
per: Fidler, S, et al.
Publicat: (2017)

Thirty years of treating HIV-1 infection: where next?
per: Frater, A
Publicat: (2015)

The Role of CD4+ T Follicular Helper Cells in HIV Infection: From the Germinal Center to the Periphery.
per: Thornhill, J, et al.
Publicat: (2017)

Immunotherapeutic approaches to HIV cure and remission
per: Lee, MJ, et al.
Publicat: (2021)

Transmitted HIV type 1 drug resistance among individuals with recent HIV infection in East and Southern Africa.
per: Price, M, et al.
Publicat: (2011)

Early antiretroviral therapy reduces hiv dna following perinatal HIV infection
per: Foster, C, et al.
Publicat: (2017)

Plasma HIV viral rebound following protocol-indicated cessation of ART commenced in primary and chronic HIV infection
per: Hamlyn, E, et al.
Publicat: (2012)

Advancing the HIV cure agenda: the next 5 years.
per: Thornhill, J, et al.
Publicat: (2015)

Primary HIV-1 subtype C infection in Ethiopia.
per: Rinke de Wit, T, et al.
Publicat: (2002)

Closing in on HIV drug resistance.
per: Larder, B, et al.
Publicat: (1999)

Impact of baseline polymorphisms in RT and protease on outcome of highly active antiretroviral therapy in HIV-1-infected African patients.
per: Frater, A, et al.
Publicat: (2001)

Cytotoxic T lymphocytes and viral evolution in primary HIV-1 infection.
per: Price, D, et al.
Publicat: (1999)

B-cell depletion reveals a role for antibodies in the control of chronic HIV-1 infection
per: Huang, K, et al.
Publicat: (2010)

Innate immune responses in primary HIV-1 infection.
per: Borrow, P, et al.
Publicat: (2008)

A randomized controlled trial of genotypic HIV drug resistance testing in HIV-1-infected children: the PERA (PENTA 8) trial.
per: Green, H, et al.
Publicat: (2006)

Slower CD4 cell decline following cessation of a 3 month course of HAART in primary HIV infection: findings from an observational cohort.
per: Fidler, S, et al.
Publicat: (2007)

The impact of HIV-1 subtype on the clinical response on HAART.
per: Frater, J
Publicat: (2002)

The impact of immunoglobulin in acute HIV infection on the HIV reservoir: a randomized controlled trial
per: Tiraboschi, J, et al.
Publicat: (2017)

The impact of immunoglobulin in acute HIV infection on the HIV reservoir: a randomized controlled trial
per: Tiraboschi, J, et al.
Publicat: (2017)

Structured observations reveal slow HIV-1 CTL escape
per: Roberts, H, et al.
Publicat: (2015)

Astrocytes resist HIV-1 fusion but engulf infected macrophage material
per: Russell, R, et al.
Publicat: (2017)

Direct visualization of HIV-1-specific cytotoxic T lymphocytes during primary infection.
per: Wilson, J, et al.
Publicat: (2000)